Skip Navigation

Breast Cancer

Publications: Breast Cancer Center of Excellence

Some of the Breast Cancer Center of Excellence’s recent publications:


Vitolins MZ, Milliron BJ, Hopkins JO, Fulmer A, Lawrence J, Melin S, Case D. Weight loss intervention in survivors of ER/PR-negative breast cancer. Clin Med Insights Womens Health. 2014;7():17-24.


Sun Y, Howard-McNatt M. Intracystic papillary carcinoma of the breast in a male patient. Am Surg. 2014;80(3):E84-E85.


Klepin HD, Pitcher BN, Ballman KV, Kornblith AB, Hurria A, Winer EP, Hudis C, Cohen HJ, Muss HB, Kimmick GG. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (Alliance). J Oncol Pract. 2014;10(5):e285-e292.


Sohl SJ, Levine B, Case LD, Danhauer SC, Avis NE. Trajectories of illness intrusiveness domains following a diagnosis of breast cancer. Health Psychol. 2014;33(3):232-241.


Bryan M, D'Agostino R, Brown D, Levine E, Howard-McNatt M. Is postmastectomy radiation therapy indicated in patients with close or positive margins? [abstract]. Ann Surg Oncol. 2014;21(Suppl 2):33.


Ahmed S, Lawrence J, Stewart JH, Melin S, Levine EA, Howard-McNatt M. Does age predict outcome in patients with inflammatory breast cancer?. Am Surg. 2014;80(8):E221-E224.


Lee E, Levine EA, Franco VI, Allen GO, Gong F, Zhang Y, Hu JJ. Combined genetic and nutritional risk models of triple negative breast cancer. Nutr Cancer. 2014;66(6):955-963.


Stolier AJ, Levine EA. Reducing the risk of nipple necrosis: technical observations in 340 nipple-sparing mastectomies. Breast J. 2013;19(2):173-179.


Howard-McNatt M, Lawrence J, Melin SA, Levine EA, Shen P, Stewart JH IV. Race and recurrence in women who undergo neoadjuvant chemotherapy for breast cancer. Am J Surg. 2013;205(4):397-401.


O'Flaherty JT, Wooten RE, Samuel MP, Thomas MJ, Levine EA, Case LD, Akman SA, Edwards IJ. Fatty acid metabolites in rapidly proliferating breast cancer. PLoS One. 2013;8(5):e63076.


Rugo HS, Serrurier K, Melisko M, Glencer A, Hwang J, D'Agostino R, Hutchens S, Esserman L, Melin S. The Dignicap System to prevent alopecia in women receiving chemotherapy for breast cancer [abstract]. Breast. 2013;22(Suppl 1):S119.


Lawrence JA, Akman SA, Melin SA, Case LD, Schwartz GG. Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial. Cancer Biol Ther. 2013;14(6):476-480.


Howard-McNatt M. Pros and cons of screening for BRCA mutations. N C Med J. 2013;74(6):489-490.


Danhauer SC, Case LD, Tedeschi R, Russell G, Vishnevsky T, Triplett K, Ip EH, Avis NE. Predictors of posttraumatic growth in women with breast cancer. Psychooncology. 2013;22(12):2676-2683.


Swain SM, Tang G, Geyer CE Jr, Rastogi P, Atkins JN, Donnellan PP, Fehrenbacher L, Azar CA, Robidoux A, Polikoff JA, Brufsky AM, Biggs DD, Levine EA, Zapas JL, Provencher L, Northfelt DW, Paik S, Costantino JP, Mamounas EP, Wolmark N.Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. J Clin Oncol. 2013;31(26):3197-3204.


Hu JJ, Lee EM, Allen GO, Levine EA. Combined genetic and nutritional risk models of triple negative breast cancer [abstract]. Cancer Res. 2013;73(8 Suppl 1):A1284.

Last Updated: 07-19-2016
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.